14-day RSI
58.05
+0.70+1.22%
03 January 2025
Summary:
Inhibikase Therapeutics stock 14-day relative strength index is 58.05, with the most recent change of +0.70 (+1.22%) on 03 January 2025. According to this value, IKT stock is neither oversold nor overboughtIKT RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +1.2% | -1.8% | +0.9% | +0.4% |
| 1 m1 month | -17.5% | -1.5% | +28.3% | +5.3% |
| 3 m3 months | +14.4% | +153.1% | +115.7% | +9.3% |
| 6 m6 months | +80.2% | +179.3% | +80.5% | +15.8% |
| ytdytd | +2.9% | -0.3% | +1.6% | +0.7% |
| 1 y1 year | -3.1% | +141.8% | +161.0% | -21.1% |
| 5 y5 years | - | - | - | - |
IKT RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 79.27 | -26.8% | 49.77 | +16.6% |
| 3 m | 3 months | 86.50 | -32.9% | 40.35 | +43.9% |
| 6 m | 6 months | 86.50 | -32.9% | 31.58 | +83.8% |
| 1 y | 1 year | 88.70 | -34.5% | 19.73 | +194.2% |
| 3 y | 3 years | 88.70 | -34.5% | 18.01 | +222.3% |
| 5 y | 5 years | 88.70 | -34.5% | 0.00 | -100.0% |
| alltime | all time | 88.70 | -34.5% | 0.00 | -100.0% |
Inhibikase Therapeutics Stock RSI History
| Date | Value |
|---|---|
| 2025 | 58.05(+2.9%) |
| 2024 | 56.40(0.0%) |
| 2023 | 56.40(+33.4%) |
| Date | Value |
|---|---|
| 2022 | 42.28(+10.7%) |
| 2021 | 38.18(>+9900.0%) |
| 2020 | 0.00 |
FAQ
- What is Inhibikase Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Inhibikase Therapeutics?
What is Inhibikase Therapeutics 14-day relative strength index?
The current 14-day RSI of IKT is 58.05
What is the all time high 14-day RSI for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high 14-day relative strength index is 88.70